| Amgen Beats, Updates Outlook - Zacks.com |
|
|
Zacks.com The decline reflected the impact of the implementation of the ESRD bundling strategy earlier this year. We expect dose utilization to continue declining in 2011. The potential implementation of label changes and reimbursement changes proposed by the |